June 5, 2023
The US Food and Drug Administration (FDA) has expanded the indication for ferric carboxymaltose injection (Injectafer, Daiichi Sankyo/American Regent) to include treatment of iron deficiency in […]
June 5, 2023
The once-weekly growth hormone analog somapacitan (Sogroya, Novo Nordisk) has been given the green light in both Europe and the United States for the treatment of children […]
June 1, 2023
United Healthcare (UHC) has announced it will not go forward with a plan to require prior authorization for colonoscopies and other endoscopic procedures. Instead, the giant […]
June 1, 2023
The US Food and Drug Administration (FDA) has approved another vaccine that protects adults older than 60 years from respiratory syncytial virus (RSV). Abrysvo, made by […]
June 1, 2023
The US Food and Drug Administration (FDA) has approved olaparib (Lynparza, AstraZeneca) with abiraterone and prednisone (or prednisolone) for BRCA-mutated metastatic castration-resistant prostate cancer, as determined […]
June 1, 2023
The European Commission has approved secukinumab (Cosentyx) as a treatment for adults with active, moderate to severe hidradenitis suppurativa (HS) that didn’t respond to conventional therapy. […]
May 31, 2023
The US Food and Drug Administration (FDA) has approved flotufolastat fluorine-18 (Posluma), a radiopharmaceutical for use with positron-emission tomography (PET) in prostate cancer. The product is […]
May 26, 2023
Sotagliflozin, a novel agent that inhibits sodium-glucose cotransporter (SGLT) 1 as well as SGLT2, received marketing approval from the US Food and Drug Administration (FDA) on […]
May 24, 2023
The US Food and Drug Administration (FDA) has approved the biosimilar adalimumab-aaty (Yuflyma) in a citrate-free, high-concentration formulation, the manufacturer, Celltrion, announced today. It is the […]